Skip to Content
PR Newswire

Novavax to Participate in BofA Securities 2024 Health Care Conference

Novavax to Participate in BofA Securities 2024 Health Care Conference

Novavax to Participate in BofA Securities 2024 Health Care Conference

PR Newswire

GAITHERSBURG, Md., May 13, 2024

GAITHERSBURG, Md., May 13, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will participate in the BofA Securities 2024 Health Care Conference.

Conference Details:



Fireside Chat


Date:

Wednesday, May 15, 2024

Time:

3:00 – 3:30 p.m. Pacific Daylight Time (PDT)

Location:

Encore Hotel in Las Vegas, NV

Moderator:

Alec Stranahan, PhD, Equity Research – U.S. Biopharma

Novavax participant:

John C. Jacobs, President and Chief Executive Officer



Conference


Event:

Investor Meetings

Date:

Wednesday, May 15, 2024

Recordings
A replay of the recorded fireside session will be available through the Events & Presentations page of the Company's website at ir.novavax.com for 30 days from the date of the conference.

About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to help protect against serious infectious diseases. Novavax, a global company based in Gaithersburg, Md., U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax's patented Matrix-M adjuvant to enhance the immune response. The Company's portfolio includes its COVID-19 vaccine and its pipeline includes COVID-19-Influenza Combination and stand-alone influenza vaccine candidates. In addition, Novavax's adjuvant is included in the University of Oxford and Serum Institute of India's R21/Matrix-M malaria vaccine. Please visit novavax.com and LinkedIn for more information.

Contacts:
Investors
Erika Schultz
240-268-2022
ir@novavax.com

Media
Giovanna Chandler
202-709-5563
media@novavax.com

Novavax Logo (PRNewsfoto/Novavax)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-bofa-securities-2024-health-care-conference-302143793.html

SOURCE Novavax, Inc.

Market Updates

Sponsor Center